首页> 外国专利> Methods of Using Circulating Cancer-Related Macrophage-Like Cells (CAML) to Predict Overall Survival and Progression-Free Survival in Cancer-bearing Subjects

Methods of Using Circulating Cancer-Related Macrophage-Like Cells (CAML) to Predict Overall Survival and Progression-Free Survival in Cancer-bearing Subjects

机译:使用循环癌相关巨噬细胞样细胞(CAML)预测癌症患者总生存率和无进展生存率的方法

摘要

Disclosed are means for predicting overall survival (OS) and progression free survival (PFS) of a subject with cancer, the prediction comprising circulating cancer-associated macrophages found in a biological sample, such as blood, from the subject. -Like cells (CAML) based on number and size. [Selection diagram] FIG.
机译:本发明公开了用于预测患有癌症的受试者的总生存期(OS)和无进展生存期(PFS)的方法,该预测包括在来自受试者的生物样本(例如血液)中发现的循环癌相关巨噬细胞-基于数量和大小的类细胞(CAML)。[选择图]图。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号